New Delhi [India], August 29 (ANI): The National Pharmaceutical Pricing Authority (NPPA) has been working more as a facilitator than a regulator and played an important role in ensuring the availability and affordability of medicines in the country, Union Minister of Chemical and Fertilizers Mansukh Mandaviya said on Monday.
New Delhi [India], January 26 (ANI): The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.
New Delhi [India], October 31 (ANI): India's pharma industry should gear up to address challenges arising out of climate change, biodiversity and environmental impacts, said Professor K Vijay Raghavan, Principal Scientific Adviser to the Government of India.
\
\
\
\
\
\
